Physician profile
Fitzgeraldo A Sanchez
NPI 1053440867
$3,134.73
in general payments reported to CMS, 2019-2025
8 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2021: $2,000 · 2022: $46.16 · 2023: $130 · 2024: $659 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.27 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis, INC | $2,000.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $460.95 | 2023-2025 | Sotyktu |
| Janssen Biotech, INC. | $230.00 | 2024 | Tremfya |
| Abbvie INC. | $211.48 | 2022-2025 | |
| Galderma Laboratories, L.P. | $170.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.54 | 2023 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $23.45 | 2025 | Ebglyss |
| Pfizer INC. | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fitzgeraldo Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.